Centre Hospitalier Universitaire Grenoble Alpes — Clinical Trial Site

76 Registered trials

30 Currently recruiting

Organisation

Centre Hospitalier Universitaire Grenoble Alpes

Location

Grenoble Cedex 9, France

Identifier

ORG-100007268

Address

Boulevard De La Chantourne, La Tronche, 38043, France

Departments

#2213: Internal Medicine
6001: Hematology
7ème Unité D CS10217
anesthésie-réanimation
Anesthésie/réanimation
cardiology
Centre de compétence troubles du rythme cardiaque et cardiomyopathies
Clinical Haematology
Clinical hematology
Département de dermatologie
Département de médecine vasculaire
Departement of Urological Surgery
Department of Neuroradiology and MRI
Dermatologie
Dermatology
Douleur
Emergency
Hématologie clinique
Hematology
Hepato-gastro-enterology
Hépato-gastroentérologie
hepatogastroenterologie
Hepatogastroenterology
Immunologie, Hématologie et Oncologie pédiatrique
Internal medicine
Médecine interne
Médecine Interne et Immunologie Clinique
Médecine Nucléaire
Medical Oncology
Néphrologie-Hémodialyse-Aphérèse-Transplantation
Nephrology
Nephrology - Chronic kidney disease
Nuclear Medicine
nuclear medicine unit
Oncology
Pneumologie
Pneumology
Pneumology and Physiology
Pole Digestif Service Hépato Gastroentérologie
Pôle Psychiatrie, Neurologie, Rééducation Neurologique et Médecine Légale
Pôle Thorax et Vaisseaux-Service de Pneumonologie, Oncologie-thoracique
Pôle Urgences Medecine Aigue
Service d'Anesthésie Pédiatrique, Hôpital Couple Enfant
Service d'hematologie
Service d'oncologie médicale
Service d'unité fonctionnelle d'inssufisance cardiaque
Service d’hepato-gastroenterologie
Service de cardiologie
Service de Néphrologie
Service de Néphrologie, Dialyse, Aphérèse et Transplantation Rénale
Service de pédiatrie, Immuno-hémato-oncologie pédiatrique
Service de pneumologie - 4e étage G
Service Hématologie
Service Hématologie - 6ème étage
Service Hépato-gastro- entérologie
Service Hepato-Gastroenterologie et Oncologie Digestive
Service HépatoGastroentérologie
Service hospitalo-universitaire de pneumologie et physiologie Pôle thorax et Vaisseaux
Service Oncologie
Unité des Troubles du Mouvement, Pavillon de neurologie

Clinical trials at this site (76)

Search interface

THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN … Recruiting

2022-501494-39-00 Uncontrolled Hypertension IN patients with moderate to 5 2023-03-28
EvER-ILD 2: Evaluation of Efficacy and safety of Rituximab in patients with progressive Interstitial Lung Disease (ILD) with inflammatory co… Recruiting

2022-501335-16-00 Interstitial lung disease 10 2023-01-16
TERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et b… Recruiting

2022-500643-20-00 Patients with locally advanced, metastatic or unresecta 4 2022-09-27
MetroWilms Recruiting

2022-502687-20-00 Wilms tumor 4 2022-09-14
A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary biliary cholan… Recruiting

2023-504660-41-00 Cholestatic Pruritus in Patients with Primary Biliary C 4 2022-07-11
Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting

2022-502425-18-00 Adenocarcinoma of the prostate 5 2022-04-19
Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i… Recruiting

2023-504166-37-00 Advanced ovarian, tubal or peritoneal cancer. 4 2022-02-01
A Phase 2 Trial of Combination Therapies with Adagrasib in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation Ended

2023-503714-77-00 Advanced Non-Small Cell Lung Cancer 4 2024-10-01
TocilizuMab discontinuAtion in GIant Cell Arteritis Ended

2023-505515-21-00 Giant Cell Arteritis 5 2024-04-02
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function (Varvara) Ended

2022-503091-89-00 Delayed graft function 4 2024-02-15
FILOAML-RR-01-OGILAR: Open-label, phase 2 study investigating the efficacy and safety of the addition of oral-azacitidine to salvage treatme… Ended

2022-501372-25-00 Patients aged 18 years and older with relapsed or refra 4 2024-01-10
Study of safety, tolerability and efficacy of DFV890 in adult participants with myeloid diseases Ended

2022-501406-36-00 Myeloid disease 3 2023-12-14
Determine effectiveness of Anifrolumab In Systemic sclerosis Ended

2023-505976-31-00 Systemic Sclerosis (SSc) presenting with Limited or Dif 5 2023-11-24
Trial of efficacy and safety of MC0518 versus best available therapy in patients with steroid-refractory acute graft versus host disease Ended

2023-503952-28-00 Steroid refractory Acute Graft versus host Disease 4 2023-11-13
A randomized, double-blind 2-arm NEPTUNUS extension study to assess the long-term safety and efficacy of ianalumab in patients with Sjögren’… Ended

2022-502966-26-01 Sjögren’s syndrome 5 2023-10-27
A Study to Evaluate Atezolizumab and Bevacizumab, with and without Tiragolumab, In Patients With Untreated Locally Advanced or Metastatic He… Ended

2023-503422-39-00 Hepatocellular Carcinoma (HCC) 5 2023-10-20
A study to compare the study treatment darolutamide in combination with androgen deprivation therapy (ADT) to placebo in combination with AD… Ended

2022-501343-33-00 Biochemically recurrent prostate cancer 5 2023-10-18
1L LUSPA VS ESA IN NTD LOW-RISK MDS PATIENTS Ended

2022-500430-29-00 Myelodysplastic Syndrome (MDS) 5 2023-10-11
A trial to see if the combination of fianlimab with cemiplimab works better than pembrolizumab for preventing or delaying melanoma from com… Ended

2022-501576-25-00 Melanoma 5 2023-07-07
HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation. Ended

2022-501939-16-00 Heart failure (HF) with mildly reduced ejection fractio 5 2023-05-09
IFCT-2201 ADAPTABLE A study evaluating the combination of paclitaxel-bevacizumab ± atezolizumab in patients with advanced lung cancer progre… Ended

2022-502103-30-00 advanced non-squamous non-small cell lung cancer 4 2023-04-25
PRODIGE 81-FFCD 2101-TRIPLET: Study evaluating the benefit of adding Ipilimumab to the combination of Atezolizumab and Bevacizumab in patien… Ended

2022-501217-31-00 Hepatocellular carcinoma 10 2023-03-09
Dupilumab step-down strategy to maintain remission in adult and adolescents patients with atopic dermatitis: a non-inferiority randomized tr… Ended

2022-501179-23-00 atopic dermatitis 6 2023-03-08
Phase 1b study investigating the association of NP137 with Atezolizumab-Bevacizumab combination in first line in unresectable hepatocellular… Ended

2022-500903-38-00 unresectable hepatocellular carcinoma 3 2023-02-09